WHO_HTM_TB_2010_13_10

Children with proven or suspected pulmonary tuberculosis or tuberculous meningitis
caused by multiple drug-resistant bacilli can be treated with a fluoroquinolone in the
context of a well-functioning MDR-TB control programme and within an appropriate
MDR-TB regimen. The decision to treat should be taken by a clinician experienced in
managing paediatric tuberculosis.

Grade Certainty of evidence
Grade Strength
Grade Certainty of evidence label
Recommendation Direction